Raltegravir Exhibits More Lipid-Friendly Profile Than Efavirenz, STARTMRK Subanalysis Finds - The Body

Links shared publicly online about this topic.

  • 1,722
    total visits

Raltegravir Exhibits More Lipid-Friendly Profile Than Efavirenz, STARTMRK Subanalysis Finds - The Body

thebody.com —

Raltegravir Exhibits More Lipid-Friendly Profile Than Efavirenz, STARTMRK Subanalysis Finds, at The Body, the complete HIV/AIDS resource.

View full resource at thebody.com

Tags: Blood Sugar, HIV, AIDS, HIV Medication, STD, Sustiva, Isentress

  • Share

Most Recently Shared on September 26, 2009 at 12:05 am By:

TheBodyDotCom The Body

Isentress Has Smaller Impact on Lipids, Blood Sugar Than Sustiva, Study Finds: http://is.gd/3FpPC #HIV #AIDS #icaac2009 #research

3 years ago...

Reply

Retweet

Favorite

Advertisement